Become A Research Partner

National Brain Tumor Society funds only the most promising research poised to deliver results. Our funded research has contributed to the establishment of many of what are now the top adult and pediatric brain tumor research labs across the country, as well as advances in understanding brain tumor makeup and what could drive more effective treatments.

By partnering with us and supporting our strategic initiatives, you can help advance the understanding of brain tumors, improve the availability of new treatments, and drive the discovery of a cure. Learn more about the initiatives that you can contribute to directly.

Defeat GBM

Glioblastoma multiforme (GBM) is a highly aggressive, complex, and devastating form of brain cancer, effecting hundreds of people each day. We believe it is our duty to accelerate progress against this disease so we launched the Defeat GBM Research Collaborative in 2013 with the intent to double the 5 year survival rate of GBM patients. This comes at a time when collaboration is becoming the norm and the abundance of genomic data is accelerating diagnostic, prognostic, and therapeutic progress.

Oligo Research Fund

Oligodendroglioma (oligo) is a relatively rare brain tumor representing about 6% of gliomas, with a diagnosis rate of about 1,150 patients a year in the U.S. alone. Critical research is required to deliver oligo patients new therapies that are more durable and extend their lives. In order to make effective, targeted therapies a reality it is essential to identify and understand the molecular drivers of the tumor’s genesis and maintenance, as well as resistance.

Pediatric Initiatives

Our new pediatric initiative, Project Impact, will leverage increases in knowledge gained from earlier funded research efforts, and develop a program that can address critical barriers to progress within the drug discovery and development pipeline through an integrated approach to advance research toward new treatments for pediatric brain tumor patients.

Community Research

The Community Research Fund allows contributors to pool donations to support research on a specific type of tumor. This program leverages a team of highly experienced, nationally-recognized scientific experts, working with National Brain Tumor Society staff, to determine the best investment strategy for each fund.

From the Blog

  • October 6, 2015

    National Brain Tumor Society Statement on FDA Approval of Optune for Treatment of Glioblastoma Patients

    National Brain Tumor Society (NBTS) interim Chief Executive Officer David Arons issued the following statement on the U.S. Food and Drug Administration’s (FDA) approval yesterday of Novocure’s Optune, a medical device to treat newly diagnosed glioblastoma multiforme (GBM) patients in combination with the chemotherapy temozolomide (brand name: Temodar) following standard treatment of surgery an

    Read More

  • October 1, 2015

    CCAM and NBTS: A recap of pediatric brain tumor news


    As another Childhood Cancer Awareness Month (CCAM) comes to a close, the National Brain Tumor Society wants to thank all of you for attending our events, sharing your stories, and doi

    Read More

  • October 1, 2015

    National Brain Tumor Society Teams Up With The V Foundation for Cancer Research To Fight Pediatric Brain Tumors

    National Brain Tumor Society, the largest nonprofit organization dedicated to the brain tumor community in the United States, today announced that it teamed up with The V Foundation for Cancer Research, one of the nation’s leading cancer research funding organizations, to fund pediatric brain tumor research. Both organizations plan to help fund a new, innovative […]

    Read More

More from the blog